Viking Global Investors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Viking Global Investors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-211,869	Closed	-$28M	–	79
2017 Q4	$28M	Sell	211,869 -491,987	-70%	-$57.8M	0.17%	52
2017 Q3	$71.4M	Sell	703,856 -169,452	-19%	-$18.1M	0.46%	43
2017 Q2	$87.5M	Buy	873,308 +38,703	+5%	+$4.17M	0.59%	34
2017 Q1	$101M	Sell	834,605 -76,226	-8%	-$9.35M	0.45%	40
2016 Q4	$102M	Sell	910,831 -71,824	-7%	-$8.65M	0.46%	41
2016 Q3	$130M	Buy	982,655 +151,108	+18%	+$14.4M	0.56%	36
2016 Q2	$76.1M	Buy	+831,547	New	+$70M	0.32%	48

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Viking Global Investors's GWPH Position: Q1 2018 in Review

Viking Global Investors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 211,869 shares — an estimated $28M sold.

Viking Global Investors first reported a position in GWPH in Q2 2016 and held it in 7 quarters. The position peaked at $130M in Q3 2016. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

Viking Global Investors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
Viking Global Investors sold 211,869 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $28M.
Viking Global Investors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 7 quarters.
Viking Global Investors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $130M in Q3 2016.
191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Viking Global Investors's 13F filing for Q1 2018, filed 15 May 2018.